We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Visceral leishmaniasis complicated by hemophagocytic lymphohistiocytosis: A case report from a nonendemic area.
- Authors
Joudeh, Anwar I.; Elsiddig Awadelkarim, Hussein A.; Gul, Mohammadshah Isam; Elayana, Mahmoud Salm; Soliman, Dina Sameh; Amer, Aliaa; Alsamawi, Musaed
- Abstract
Key Clinical Message: Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many features in common and may coincide in the same patient. Timely diagnosis and management of visceral leishmaniasis could save patients from unnecessary toxic treatment. Visceral leishmaniasis and hemophagocytic lymphohistiocytosis share many clinical features in common and may coexist in the same patient. Visceral leishmaniasis should be promptly ruled out in patients coming from endemic areas before starting immunosuppressive therapy for hemophagocytic lymphohistiocytosis. The mainstay treatment, in this case, is anti‐leishmania medications preferably liposomal amphotericin‐B.
- Subjects
VISCERAL leishmaniasis; HEMOPHAGOCYTIC lymphohistiocytosis; IMMUNOSUPPRESSIVE agents; MACROPHAGE activation syndrome
- Publication
Clinical Case Reports, 2023, Vol 11, Issue 5, p1
- ISSN
2050-0904
- Publication type
Case Study
- DOI
10.1002/ccr3.7309